MTOR and cervical cancer: Given that PIK3CA is well known to be overexpressed in cervical cancer and that miR-29a has demonstrated growth inhibitory effects in various tumors by modulating the PI3K/AKT/mTOR signaling pathway, we conducted this study to determine whether miR-29a directly affects PIK3CA.